Literature DB >> 21647581

Lenalidomide is active for extramedullary disease in refractory multiple myeloma.

Tomonori Nakazato, Ai Mihara, Chisako Ito, Yukinari Sanada, Yoshinobu Aisa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21647581     DOI： 10.1007/s00277-011-1272-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  7 in total

Review 1.  Extramedullary multiple myeloma.

Authors:  Manisha Bhutani; David M Foureau; Shebli Atrash; Peter M Voorhees; Saad Z Usmani
Journal:  Leukemia       Date:  2019-11-27       Impact factor: 11.528

2.  Successful treatment with lenalidomide of secondary multiple myeloma with extramedullary liver plasmacytoma in a renal transplant recipient: A case report and review of the literature.

Authors:  Xiaobao Xie; Wei Wu; Yuandong Zhu; Deliang Liu; Weimin Dong; Haiqian Li; Qing Li; Weiying Gu
Journal:  Oncol Lett       Date:  2015-09-18       Impact factor: 2.967

3.  Refractory multiple myeloma with extramedullary plasmacytoma of the spleen and suspicious teratoma: a rare case report and literature review.

Authors:  Peipei Xu; Hong Chu; Xiaoyan Shao; Ying Jiang; Chaoyang Guan; Ming Chen; Bing Chen
Journal:  Int J Clin Exp Pathol       Date:  2021-04-15

Review 4.  Extramedullary plasmacytoma mimicking colon carcinoma: an unusual presentation and review of the literature.

Authors:  Kaela Parnell; Mashrafi Ahmed; Roger D Smalligan; Suhasini Nadesan
Journal:  BMJ Case Rep       Date:  2015-10-23

5.  Clinical Characteristics and Prognostic Analysis of Multiple Myeloma with Extramedullary Disease: A SEER-Based Study.

Authors:  Guang Li; Yan-Ping Song; Yao Lv; Zhen-Zhen Li; Yan-Hua Zheng
Journal:  J Oncol       Date:  2021-01-30       Impact factor: 4.375

Review 6.  Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance.

Authors:  Vincenzo Sammartano; Alfonso Cerase; Valentina Venanzi; Maria Antonietta Mazzei; Beatrice Esposito Vangone; Francesco Gentili; Ivano Chiarotti; Monica Bocchia; Alessandro Gozzetti
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

7.  Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies.

Authors:  Lourdes Farre; Gabriela Sanz; Neus Ruiz-Xivillé; Manuel Castro de Moura; Juan Francisco Martin-Tejera; Samuel Gonçalves-Ribeiro; Maria Martinez-Iniesta; Monica Calaf; Jose Luis Mosquera; José Ignacio Martín-Subero; Isabel Granada; Manel Esteller; Eva Domingo-Domenech; Fina Climent; Alberto Villanueva; Anna Sureda
Journal:  Dis Model Mech       Date:  2021-07-15       Impact factor: 5.758
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.